Abstract
Recently, two genome-wide association studies identified single nucleotide polymorphisms (SNPs) significantly associated with the treatment response to tumor necrosis factor α (TNFα) inhibitors in patients with rheumatoid arthritis (RA). We aimed to replicate these results and identify SNPs and the possible biological pathways associated with the treatment response to TNFα inhibitors.
Original language | English |
---|---|
Journal | Pharmacogenetics and Genomics |
Volume | 22 |
Issue number | 8 |
Pages (from-to) | 577-89 |
Number of pages | 13 |
ISSN | 1744-6872 |
DOIs | |
Publication status | Published - 2012 |